Protective Effects of Salidroside against Carbon Tetrachloride (CCl4)-Induced Liver Injury by Initiating Mitochondria to Resist Oxidative Stress in Mice

Int J Mol Sci. 2019 Jun 28;20(13):3187. doi: 10.3390/ijms20133187.

Abstract

The antioxidant effect of salidroside has been proven, but its role in liver injury is poorly understood. In this study, we aimed to evaluate the protective effects and mechanism of salidroside on liver injury induced by carbon tetrachloride (CCl4) in vivo. Mice were pretreated with salidroside (60 mg/kg, intraperitoneally injected, i.p.) once per day for 14 consecutive days and then administered with CCl4 (15.95 g/kg, i.p.) for 24 h to produce a liver injury model. Salidroside attenuated hepatic transaminase elevation in serum and ameliorated liver steatosis and necrosis, thereby suggesting its protective effect on the liver. Salidroside antagonized CCl4-induced toxicity by equilibrating antioxidation system, thereby inhibiting reactive oxygen species accumulation, and restoring mitochondrial structure and function. Salidroside exerts antioxidant and liver-protective effects by selectively inhibiting the activation of genes, including growth arrest and DNA -damage-inducible 45 α (Gadd45a), mitogen-activated protein kinase 7 (Mapk7), and related RAS viral oncogene homolog 2 (Rras2), which induce oxidative stress in the mitogen-activated protein kinase pathway. These results revealed that salidroside can protect the liver from CCl4-induced injury by resisting oxidative stress and protecting mitochondrial function.

Keywords: CCl4; Salidroside; liver injury; mitochondria; oxidative stress.

MeSH terms

  • Animals
  • Antioxidants* / pharmacology
  • Antioxidants* / therapeutic use
  • Carbon Tetrachloride / toxicity
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Chemical and Drug Induced Liver Injury* / drug therapy
  • Chemical and Drug Induced Liver Injury* / metabolism
  • Chemical and Drug Induced Liver Injury* / prevention & control
  • Glucosides* / pharmacology
  • Glucosides* / therapeutic use
  • MAP Kinase Signaling System
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mice
  • Microtubule-Associated Proteins / genetics
  • Microtubule-Associated Proteins / metabolism
  • Mitochondria, Liver* / drug effects
  • Mitochondria, Liver* / metabolism
  • Monomeric GTP-Binding Proteins / genetics
  • Monomeric GTP-Binding Proteins / metabolism
  • Oxidative Stress*
  • Phenols* / pharmacology
  • Phenols* / therapeutic use

Substances

  • Antioxidants
  • Carbon Tetrachloride
  • Cell Cycle Proteins
  • Gadd45a protein, mouse
  • Glucosides
  • Membrane Proteins
  • Microtubule-Associated Proteins
  • Monomeric GTP-Binding Proteins
  • Phenols
  • rhodioloside
  • Rras2 protein, mouse
  • MAP7 protein, mouse